225 related articles for article (PubMed ID: 14695825)
41. A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains.
Wannberg J; Sabnis YA; Vrang L; Samuelsson B; Karlén A; Hallberg A; Larhed M
Bioorg Med Chem; 2006 Aug; 14(15):5303-15. PubMed ID: 16621572
[TBL] [Abstract][Full Text] [Related]
42. Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
Abdel-Rahman HM; Kimura T; Hidaka K; Kiso A; Nezami A; Freire E; Hayashi Y; Kiso Y
Biol Chem; 2004 Nov; 385(11):1035-9. PubMed ID: 15576323
[TBL] [Abstract][Full Text] [Related]
43. Inhibitors of Plasmepsin II-potential antimalarial agents.
Corminboeuf O; Dunet G; Hafsi M; Grimont J; Grisostomi C; Meyer S; Binkert C; Bur D; Jones A; Prade L; Brun R; Boss C
Bioorg Med Chem Lett; 2006 Dec; 16(24):6194-9. PubMed ID: 17000102
[TBL] [Abstract][Full Text] [Related]
44. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
[TBL] [Abstract][Full Text] [Related]
45. [Selective inhibitors of plasmepsin II from Plasmodium falciparum based on pepstatin].
Rumsh LD; Mikhaĭlova AG; Mikhura IV; Prudchenko IA; Chikin LD; Mikhaleva II; Kaliberda EN; Dergousova NI; Mel'nikov EE; Formanovskiĭ AA
Bioorg Khim; 2008; 34(6):739-46. PubMed ID: 19088746
[TBL] [Abstract][Full Text] [Related]
46. Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.
Haque TS; Skillman AG; Lee CE; Habashita H; Gluzman IY; Ewing TJ; Goldberg DE; Kuntz ID; Ellman JA
J Med Chem; 1999 Apr; 42(8):1428-40. PubMed ID: 10212129
[TBL] [Abstract][Full Text] [Related]
47. Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV.
Boss C; Corminboeuf O; Grisostomi C; Meyer S; Jones AF; Prade L; Binkert C; Fischli W; Weller T; Bur D
ChemMedChem; 2006 Dec; 1(12):1341-5. PubMed ID: 17091526
[No Abstract] [Full Text] [Related]
48. Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.
Li T; Yowell CA; Beyer BB; Hung SH; Westling J; Lam MT; Dunn BM; Dame JB
Mol Biochem Parasitol; 2004 May; 135(1):101-9. PubMed ID: 15287591
[TBL] [Abstract][Full Text] [Related]
49. Identification of Sulfamoylbenzamide derivatives as selective Cathepsin D inhibitors.
Ahmed W; Khan IA; Arshad MN; Siddiqui WA; Haleem MA; Azim MK
Pak J Pharm Sci; 2013 Jul; 26(4):687-90. PubMed ID: 23811443
[TBL] [Abstract][Full Text] [Related]
50. Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum.
Asojo OA; Gulnik SV; Afonina E; Yu B; Ellman JA; Haque TS; Silva AM
J Mol Biol; 2003 Mar; 327(1):173-81. PubMed ID: 12614616
[TBL] [Abstract][Full Text] [Related]
51. Plasmepsin inhibitors: design, synthesis, inhibitory studies and crystal structure analysis.
Kesavulu MM; Prakasha Gowda AS; Ramya TN; Surolia N; Suguna K
J Pept Res; 2005 Oct; 66(4):211-9. PubMed ID: 16138859
[TBL] [Abstract][Full Text] [Related]
52. Plasmodium falciparum, P. vivax, and P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite.
Westling J; Yowell CA; Majer P; Erickson JW; Dame JB; Dunn BM
Exp Parasitol; 1997 Nov; 87(3):185-93. PubMed ID: 9371083
[TBL] [Abstract][Full Text] [Related]
53. Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax.
Sleebs BE; Gazdik M; O'Neill MT; Rajasekaran P; Lopaticki S; Lackovic K; Lowes K; Smith BJ; Cowman AF; Boddey JA
J Med Chem; 2014 Sep; 57(18):7644-62. PubMed ID: 25167370
[TBL] [Abstract][Full Text] [Related]
54. 2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.
Rasina D; Stakanovs G; Borysov OV; Pantelejevs T; Bobrovs R; Kanepe-Lapsa I; Tars K; Jaudzems K; Jirgensons A
Bioorg Med Chem; 2018 May; 26(9):2488-2500. PubMed ID: 29636223
[TBL] [Abstract][Full Text] [Related]
55. C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions.
Ersmark K; Feierberg I; Bjelic S; Hultén J; Samuelsson B; Aqvist J; Hallberg A
Bioorg Med Chem; 2003 Aug; 11(17):3723-33. PubMed ID: 12901917
[TBL] [Abstract][Full Text] [Related]
56. Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
Kumar Singh A; Rajendran V; Singh S; Kumar P; Kumar Y; Singh A; Miller W; Potemkin V; Poonam ; Grishina M; Gupta N; Kempaiah P; Durvasula R; Singh BK; Dunn BM; Rathi B
Bioorg Med Chem; 2018 Jul; 26(13):3837-3844. PubMed ID: 29983285
[TBL] [Abstract][Full Text] [Related]
57. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
[TBL] [Abstract][Full Text] [Related]
58. Plasmepsin II inhibitory activity of alkoxylated and hydroxylated chalcones.
Sriwilaijaroen N; Liu M; Go ML; Wilairat P
Southeast Asian J Trop Med Public Health; 2006 Jul; 37(4):607-12. PubMed ID: 17121282
[TBL] [Abstract][Full Text] [Related]
59. New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships.
Saify ZS; Azim MK; Ahmad W; Nisa M; Goldberg DE; Hussain SA; Akhtar S; Akram A; Arayne A; Oksman A; Khan IA
Bioorg Med Chem Lett; 2012 Jan; 22(2):1282-6. PubMed ID: 22204908
[TBL] [Abstract][Full Text] [Related]
60. Mapping selectivity and specificity of active site of plasmepsins from Plasmodium falciparum using molecular interaction field approach.
Kumar A; Ghosh I
Protein Pept Lett; 2007; 14(6):569-74. PubMed ID: 17627598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
